Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.7 | estrogen receptor 2 (beta) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_76196353_76196637 | Esr2 | 19236 | 0.135073 | -0.78 | 7.0e-02 | Click! |
chr12_76196151_76196305 | Esr2 | 18969 | 0.135692 | 0.67 | 1.5e-01 | Click! |
chr12_76177934_76178097 | Esr2 | 756 | 0.618015 | -0.62 | 1.9e-01 | Click! |
chr12_76196723_76196890 | Esr2 | 19547 | 0.134349 | -0.58 | 2.3e-01 | Click! |
chr12_76191077_76191241 | Esr2 | 13900 | 0.147208 | -0.58 | 2.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_116321877_116322041 | 9.44 |
Gm29151 |
predicted gene 29151 |
28144 |
0.15 |
chr8_10873138_10873312 | 8.69 |
Gm32540 |
predicted gene, 32540 |
7039 |
0.11 |
chr5_118292276_118292427 | 8.20 |
Gm25076 |
predicted gene, 25076 |
25902 |
0.16 |
chr3_116321617_116321772 | 7.94 |
Gm29151 |
predicted gene 29151 |
28409 |
0.15 |
chr9_43673281_43673432 | 6.81 |
Gm5364 |
predicted gene 5364 |
9697 |
0.16 |
chr17_86661961_86662112 | 6.75 |
Gm18832 |
predicted gene, 18832 |
23460 |
0.19 |
chr4_137810112_137810287 | 6.72 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
13815 |
0.19 |
chr4_124670340_124670505 | 6.59 |
Gm2164 |
predicted gene 2164 |
13253 |
0.09 |
chr16_17307555_17307706 | 6.44 |
Pi4ka |
phosphatidylinositol 4-kinase alpha |
100 |
0.95 |
chr12_24463539_24463734 | 6.37 |
Gm16372 |
predicted pseudogene 16372 |
30020 |
0.14 |
chr12_108046568_108046785 | 6.34 |
Bcl11b |
B cell leukemia/lymphoma 11B |
43074 |
0.17 |
chr11_88926781_88926936 | 6.30 |
Scpep1os |
serine carboxypeptidase 1, opposite strand |
20930 |
0.1 |
chr8_119442578_119443025 | 6.25 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
3918 |
0.18 |
chr1_171382425_171382584 | 6.11 |
Arhgap30 |
Rho GTPase activating protein 30 |
6450 |
0.07 |
chr18_46337024_46337197 | 6.09 |
4930415P13Rik |
RIKEN cDNA 4930415P13 gene |
3319 |
0.19 |
chr1_72830155_72830306 | 5.90 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
4908 |
0.25 |
chr7_126230828_126230994 | 5.76 |
Gm44703 |
predicted gene 44703 |
11716 |
0.12 |
chr3_36468925_36469086 | 5.76 |
Mir7009 |
microRNA 7009 |
6519 |
0.12 |
chr12_108856815_108857551 | 5.74 |
Gm22079 |
predicted gene, 22079 |
5486 |
0.1 |
chr1_78081905_78082084 | 5.74 |
Gm28387 |
predicted gene 28387 |
109618 |
0.06 |
chr16_35727863_35728078 | 5.67 |
Gm25967 |
predicted gene, 25967 |
5737 |
0.18 |
chr13_73723026_73723388 | 5.67 |
Slc12a7 |
solute carrier family 12, member 7 |
9887 |
0.15 |
chr12_83055899_83056080 | 5.66 |
Rgs6 |
regulator of G-protein signaling 6 |
8999 |
0.21 |
chr10_8233280_8233441 | 5.65 |
Gm30906 |
predicted gene, 30906 |
57229 |
0.14 |
chr11_58225731_58226335 | 5.65 |
Gm5038 |
predicted gene 5038 |
5417 |
0.12 |
chr2_127603534_127603695 | 5.59 |
Mrps5 |
mitochondrial ribosomal protein S5 |
3581 |
0.16 |
chr1_189006324_189006498 | 5.58 |
Kctd3 |
potassium channel tetramerisation domain containing 3 |
1417 |
0.48 |
chr18_55475354_55475538 | 5.56 |
Gm37337 |
predicted gene, 37337 |
41668 |
0.2 |
chr5_121950251_121950441 | 5.51 |
Cux2 |
cut-like homeobox 2 |
25425 |
0.15 |
chr11_7184254_7184557 | 5.46 |
Ccdc201 |
coiled coil domain 201 |
4164 |
0.2 |
chr17_29513002_29513355 | 5.39 |
Gm17657 |
predicted gene, 17657 |
6612 |
0.11 |
chr5_145982849_145983558 | 5.39 |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
8440 |
0.13 |
chr12_21526957_21527150 | 5.38 |
Gm19196 |
predicted gene, 19196 |
16254 |
0.22 |
chr9_120731019_120731170 | 5.34 |
Gm47064 |
predicted gene, 47064 |
20049 |
0.12 |
chr12_88818907_88819069 | 5.29 |
Nrxn3 |
neurexin III |
23549 |
0.23 |
chr4_148448716_148449227 | 5.24 |
Mtor |
mechanistic target of rapamycin kinase |
346 |
0.82 |
chr4_136689035_136689208 | 5.15 |
Ephb2 |
Eph receptor B2 |
4919 |
0.19 |
chr6_71235183_71235374 | 5.14 |
Smyd1 |
SET and MYND domain containing 1 |
18404 |
0.1 |
chr11_7203035_7203187 | 5.14 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
5329 |
0.19 |
chr12_112428711_112428862 | 5.13 |
A730018C14Rik |
RIKEN cDNA A730018C14 gene |
5574 |
0.16 |
chr19_42602482_42602861 | 5.10 |
Loxl4 |
lysyl oxidase-like 4 |
650 |
0.71 |
chr8_94217878_94218059 | 5.10 |
Nup93 |
nucleoporin 93 |
3362 |
0.14 |
chr4_42849993_42850145 | 5.04 |
Fam205a1 |
family with sequence similarity 205, member A1 |
3819 |
0.16 |
chr12_102711766_102711920 | 5.02 |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
6913 |
0.1 |
chr11_119035192_119035358 | 4.97 |
Cbx8 |
chromobox 8 |
5556 |
0.17 |
chr4_135950014_135950187 | 4.97 |
Hmgcl |
3-hydroxy-3-methylglutaryl-Coenzyme A lyase |
1570 |
0.21 |
chr3_38541387_38541538 | 4.91 |
Gm24462 |
predicted gene, 24462 |
16752 |
0.17 |
chr10_80877174_80877325 | 4.86 |
Tmprss9 |
transmembrane protease, serine 9 |
2456 |
0.13 |
chr17_8995423_8995578 | 4.81 |
1700010I14Rik |
RIKEN cDNA 1700010I14 gene |
7117 |
0.26 |
chr2_167686580_167686731 | 4.81 |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
2260 |
0.17 |
chr11_50733265_50733435 | 4.78 |
Gm12200 |
predicted gene 12200 |
7806 |
0.16 |
chr7_134497184_134497335 | 4.75 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
1725 |
0.51 |
chr11_116083144_116083295 | 4.74 |
Wbp2 |
WW domain binding protein 2 |
1734 |
0.2 |
chr6_91491042_91491229 | 4.73 |
Tmem43 |
transmembrane protein 43 |
14535 |
0.1 |
chr10_3523296_3523476 | 4.72 |
Iyd |
iodotyrosine deiodinase |
16854 |
0.25 |
chr10_67696602_67696753 | 4.69 |
Gm47574 |
predicted gene, 47574 |
11161 |
0.16 |
chr1_119173493_119173679 | 4.68 |
Gm8321 |
predicted gene 8321 |
16000 |
0.22 |
chr1_93030160_93030324 | 4.67 |
Kif1a |
kinesin family member 1A |
3037 |
0.18 |
chr2_91130312_91130482 | 4.66 |
Madd |
MAP-kinase activating death domain |
8859 |
0.11 |
chr10_84885382_84885679 | 4.65 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
32086 |
0.17 |
chr1_191456632_191456786 | 4.65 |
Gm32200 |
predicted gene, 32200 |
8339 |
0.15 |
chr18_20989164_20989323 | 4.64 |
Rnf138 |
ring finger protein 138 |
12098 |
0.2 |
chr8_10873432_10873587 | 4.63 |
Gm32540 |
predicted gene, 32540 |
7323 |
0.11 |
chr4_45474566_45475016 | 4.62 |
Shb |
src homology 2 domain-containing transforming protein B |
8011 |
0.17 |
chr6_31148380_31148897 | 4.61 |
Gm37728 |
predicted gene, 37728 |
1219 |
0.36 |
chr2_32471688_32471890 | 4.59 |
Gm37169 |
predicted gene, 37169 |
16199 |
0.09 |
chr4_42524335_42524489 | 4.56 |
Fam205a2 |
family with sequence similarity 205, member A2 |
3763 |
0.18 |
chr4_41969804_41969958 | 4.56 |
Fam205a4 |
family with sequence similarity 205, member A4 |
3823 |
0.14 |
chr4_42322018_42322173 | 4.56 |
Fam205a3 |
family with sequence similarity 205, member A3 |
3823 |
0.14 |
chr4_59558387_59559028 | 4.52 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
9343 |
0.15 |
chr11_20396557_20396740 | 4.52 |
Gm12034 |
predicted gene 12034 |
49764 |
0.12 |
chr16_22698076_22698372 | 4.51 |
Gm8118 |
predicted gene 8118 |
12030 |
0.18 |
chr12_71875530_71876050 | 4.50 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
13940 |
0.21 |
chr1_183414419_183414590 | 4.50 |
Gm37986 |
predicted gene, 37986 |
38 |
0.96 |
chr7_101491003_101491309 | 4.50 |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
9871 |
0.14 |
chr16_11520908_11521091 | 4.47 |
Gm15897 |
predicted gene 15897 |
24693 |
0.22 |
chr11_60203795_60204262 | 4.45 |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
171 |
0.9 |
chr13_98594899_98595134 | 4.44 |
Gm4815 |
predicted gene 4815 |
18485 |
0.12 |
chr18_74624820_74624979 | 4.43 |
Myo5b |
myosin VB |
8278 |
0.25 |
chr17_28279330_28279495 | 4.40 |
Ppard |
peroxisome proliferator activator receptor delta |
7293 |
0.11 |
chr2_75564827_75565114 | 4.40 |
Gm13655 |
predicted gene 13655 |
68412 |
0.08 |
chr15_77077850_77078204 | 4.39 |
1700109K24Rik |
RIKEN cDNA 1700109K24 gene |
6371 |
0.11 |
chr10_84054746_84054912 | 4.39 |
Gm37908 |
predicted gene, 37908 |
6929 |
0.2 |
chr11_103049368_103049573 | 4.38 |
Nmt1 |
N-myristoyltransferase 1 |
20885 |
0.1 |
chr4_138440154_138440340 | 4.38 |
Mul1 |
mitochondrial ubiquitin ligase activator of NFKB 1 |
5524 |
0.14 |
chr4_144981227_144981590 | 4.37 |
Vps13d |
vacuolar protein sorting 13D |
2553 |
0.3 |
chr3_107974354_107974715 | 4.37 |
Gm12497 |
predicted pseudogene 12497 |
5098 |
0.08 |
chr11_115677637_115677828 | 4.37 |
Gm11702 |
predicted gene 11702 |
20173 |
0.09 |
chr17_47089532_47089710 | 4.36 |
Gm4945 |
predicted gene 4945 |
46582 |
0.12 |
chr17_56332362_56332517 | 4.36 |
Kdm4b |
lysine (K)-specific demethylase 4B |
6348 |
0.12 |
chr4_43234117_43234284 | 4.35 |
Unc13b |
unc-13 homolog B |
393 |
0.84 |
chr2_134792983_134793164 | 4.34 |
Plcb1 |
phospholipase C, beta 1 |
6543 |
0.2 |
chr6_91111481_91112156 | 4.33 |
Nup210 |
nucleoporin 210 |
4978 |
0.17 |
chr17_28298917_28299090 | 4.33 |
Ppard |
peroxisome proliferator activator receptor delta |
5757 |
0.11 |
chr2_68873804_68874167 | 4.31 |
Cers6 |
ceramide synthase 6 |
12399 |
0.14 |
chr18_81199680_81199982 | 4.31 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
36235 |
0.17 |
chr11_100779250_100779403 | 4.30 |
Ghdc |
GH3 domain containing |
8369 |
0.11 |
chr1_165617606_165617906 | 4.30 |
Mpzl1 |
myelin protein zero-like 1 |
3777 |
0.14 |
chr19_54834637_54834803 | 4.29 |
Gm50191 |
predicted gene, 50191 |
102004 |
0.08 |
chr8_119429067_119429280 | 4.28 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
4951 |
0.17 |
chr4_145037079_145037530 | 4.28 |
Vps13d |
vacuolar protein sorting 13D |
13730 |
0.24 |
chr8_11149308_11149679 | 4.26 |
Gm44717 |
predicted gene 44717 |
247 |
0.91 |
chr10_84055512_84055676 | 4.26 |
Gm37908 |
predicted gene, 37908 |
6164 |
0.21 |
chr7_126260333_126260533 | 4.25 |
Sbk1 |
SH3-binding kinase 1 |
11571 |
0.11 |
chr18_60748821_60749236 | 4.23 |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
378 |
0.77 |
chr13_18868717_18869129 | 4.22 |
Vps41 |
VPS41 HOPS complex subunit |
24060 |
0.18 |
chr11_94347313_94347820 | 4.22 |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
3620 |
0.18 |
chr1_191456836_191456993 | 4.22 |
Gm32200 |
predicted gene, 32200 |
8134 |
0.15 |
chr6_94166061_94166229 | 4.22 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
116880 |
0.06 |
chr12_84178717_84179096 | 4.21 |
Gm19327 |
predicted gene, 19327 |
8900 |
0.1 |
chr11_98769689_98769972 | 4.20 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
596 |
0.57 |
chr7_4651233_4651574 | 4.19 |
Ppp6r1 |
protein phosphatase 6, regulatory subunit 1 |
3998 |
0.09 |
chr12_111514450_111514666 | 4.18 |
Gm40578 |
predicted gene, 40578 |
13718 |
0.1 |
chr2_25431594_25431764 | 4.18 |
Abca2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
2976 |
0.1 |
chr1_133257148_133257349 | 4.14 |
Gm19461 |
predicted gene, 19461 |
130 |
0.89 |
chr2_91476650_91476839 | 4.12 |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
425 |
0.81 |
chr3_121195173_121195348 | 4.10 |
Gm5710 |
predicted gene 5710 |
14163 |
0.14 |
chr8_10939998_10940171 | 4.09 |
Gm44955 |
predicted gene 44955 |
7806 |
0.11 |
chr3_82952346_82952497 | 4.09 |
Gm30097 |
predicted gene, 30097 |
43164 |
0.1 |
chr2_31464685_31464877 | 4.08 |
Ass1 |
argininosuccinate synthetase 1 |
5426 |
0.2 |
chr19_45745506_45745808 | 4.07 |
Fgf8 |
fibroblast growth factor 8 |
2742 |
0.18 |
chr6_118939696_118939861 | 4.07 |
Gm25905 |
predicted gene, 25905 |
104878 |
0.07 |
chr12_109512584_109512771 | 4.07 |
Gm34081 |
predicted gene, 34081 |
4063 |
0.07 |
chr6_100062035_100062186 | 4.06 |
Gm33201 |
predicted gene, 33201 |
70895 |
0.1 |
chr10_80438140_80438330 | 4.06 |
Tcf3 |
transcription factor 3 |
4588 |
0.1 |
chr8_119443050_119443280 | 4.05 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
3554 |
0.18 |
chr4_144977157_144977352 | 4.04 |
Vps13d |
vacuolar protein sorting 13D |
6707 |
0.21 |
chr17_14168923_14169074 | 4.03 |
Gm34510 |
predicted gene, 34510 |
34730 |
0.12 |
chr4_128946455_128946665 | 4.03 |
Gm15904 |
predicted gene 15904 |
10555 |
0.15 |
chr2_71466796_71467175 | 4.02 |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
13622 |
0.13 |
chr19_58441387_58441549 | 4.02 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
12998 |
0.22 |
chr10_61337527_61337708 | 4.02 |
Pald1 |
phosphatase domain containing, paladin 1 |
4710 |
0.15 |
chr12_82855785_82855951 | 4.02 |
1700085C21Rik |
RIKEN cDNA 1700085C21 gene |
83287 |
0.09 |
chr11_86994352_86994663 | 4.01 |
Ypel2 |
yippee like 2 |
800 |
0.57 |
chr1_35933502_35933830 | 3.99 |
Gm8022 |
predicted gene 8022 |
25253 |
0.15 |
chr11_115373943_115374098 | 3.98 |
Hid1 |
HID1 domain containing |
6264 |
0.09 |
chr17_56470625_56470795 | 3.98 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
3917 |
0.18 |
chr6_72465434_72465992 | 3.97 |
Mat2a |
methionine adenosyltransferase II, alpha |
26155 |
0.1 |
chr10_44084446_44084597 | 3.95 |
Crybg1 |
crystallin beta-gamma domain containing 1 |
25743 |
0.17 |
chr18_61383552_61383876 | 3.94 |
Gm25301 |
predicted gene, 25301 |
14099 |
0.13 |
chr10_61278018_61278535 | 3.94 |
Adamts14 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 14 |
4838 |
0.17 |
chr4_117332720_117332922 | 3.93 |
Rnf220 |
ring finger protein 220 |
32793 |
0.11 |
chr7_145087928_145088130 | 3.92 |
Gm45181 |
predicted gene 45181 |
74967 |
0.09 |
chr11_107703521_107703697 | 3.91 |
Cacng1 |
calcium channel, voltage-dependent, gamma subunit 1 |
12913 |
0.16 |
chr2_167260546_167260697 | 3.91 |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
20017 |
0.13 |
chr6_108662475_108662641 | 3.90 |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
488 |
0.72 |
chr1_170501557_170501869 | 3.89 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
46799 |
0.15 |
chr2_153609102_153609438 | 3.88 |
Commd7 |
COMM domain containing 7 |
23461 |
0.15 |
chr8_66579826_66579979 | 3.86 |
Gm16330 |
predicted gene 16330 |
9106 |
0.22 |
chr11_82888693_82889019 | 3.85 |
Rad51d |
RAD51 paralog D |
1733 |
0.19 |
chr11_99081665_99081816 | 3.84 |
Tns4 |
tensin 4 |
6399 |
0.15 |
chr12_109987966_109988154 | 3.84 |
Gm34667 |
predicted gene, 34667 |
35813 |
0.09 |
chr19_4436418_4436609 | 3.83 |
A930001C03Rik |
RIKEN cDNA A930001C03 gene |
2490 |
0.17 |
chr2_91264224_91264426 | 3.83 |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
649 |
0.5 |
chr12_112119169_112119320 | 3.82 |
Aspg |
asparaginase |
710 |
0.56 |
chr8_114716336_114716627 | 3.82 |
Wwox |
WW domain-containing oxidoreductase |
4314 |
0.26 |
chr6_42221324_42221475 | 3.82 |
Tas2r144 |
taste receptor, type 2, member 144 |
6071 |
0.14 |
chr11_113725569_113725747 | 3.82 |
Cdc42ep4 |
CDC42 effector protein (Rho GTPase binding) 4 |
13664 |
0.13 |
chr14_25377112_25377271 | 3.81 |
Gm26660 |
predicted gene, 26660 |
1444 |
0.44 |
chr8_111780740_111780906 | 3.78 |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
37014 |
0.13 |
chr8_115831765_115832080 | 3.78 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
124128 |
0.06 |
chr3_132917460_132917629 | 3.78 |
Npnt |
nephronectin |
11185 |
0.16 |
chr15_99716487_99716652 | 3.77 |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
946 |
0.3 |
chr1_72854037_72854202 | 3.77 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
5420 |
0.23 |
chr9_70138613_70138777 | 3.77 |
Fam81a |
family with sequence similarity 81, member A |
2883 |
0.24 |
chr15_55819504_55819678 | 3.77 |
Sntb1 |
syntrophin, basic 1 |
86719 |
0.08 |
chr2_132740163_132740333 | 3.76 |
Gm22245 |
predicted gene, 22245 |
23142 |
0.11 |
chr4_133028994_133029156 | 3.75 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
10418 |
0.18 |
chr4_55768439_55768659 | 3.75 |
Gm12506 |
predicted gene 12506 |
163400 |
0.03 |
chr4_150858687_150859936 | 3.74 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
4238 |
0.16 |
chr5_120472850_120473198 | 3.73 |
Sdsl |
serine dehydratase-like |
214 |
0.88 |
chr11_115803396_115803584 | 3.73 |
Caskin2 |
CASK-interacting protein 2 |
2609 |
0.14 |
chr6_35874026_35874908 | 3.73 |
Gm43442 |
predicted gene 43442 |
52244 |
0.17 |
chr2_105245494_105245679 | 3.72 |
Them7 |
thioesterase superfamily member 7 |
21244 |
0.22 |
chr1_187314638_187314804 | 3.70 |
Gm38155 |
predicted gene, 38155 |
62748 |
0.1 |
chr8_115719843_115720129 | 3.70 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
12192 |
0.23 |
chr2_144168144_144168312 | 3.69 |
Gm5535 |
predicted gene 5535 |
6136 |
0.17 |
chr6_108658508_108658692 | 3.69 |
Gm17055 |
predicted gene 17055 |
1555 |
0.28 |
chr8_117339115_117339479 | 3.68 |
Cmip |
c-Maf inducing protein |
9873 |
0.26 |
chr18_68491528_68491858 | 3.68 |
Gm50258 |
predicted gene, 50258 |
58900 |
0.1 |
chr18_36527710_36528079 | 3.67 |
Slc4a9 |
solute carrier family 4, sodium bicarbonate cotransporter, member 9 |
253 |
0.88 |
chr12_111450305_111450614 | 3.65 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
60 |
0.96 |
chr3_129901851_129902495 | 3.65 |
Casp6 |
caspase 6 |
672 |
0.65 |
chr5_125170608_125171005 | 3.64 |
Ncor2 |
nuclear receptor co-repressor 2 |
8247 |
0.22 |
chr1_191224850_191225043 | 3.63 |
D730003I15Rik |
RIKEN cDNA D730003I15 gene |
472 |
0.74 |
chr8_120482328_120482479 | 3.62 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
6044 |
0.16 |
chr6_128645863_128646024 | 3.62 |
Gm5884 |
predicted pseudogene 5884 |
1030 |
0.28 |
chr5_139358617_139359046 | 3.61 |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
4255 |
0.13 |
chr13_102877226_102877399 | 3.61 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
28474 |
0.23 |
chr2_179503121_179503284 | 3.61 |
Cdh4 |
cadherin 4 |
58969 |
0.13 |
chr15_95767994_95768168 | 3.59 |
Gm8849 |
predicted gene 8849 |
7673 |
0.12 |
chr8_117324934_117325253 | 3.58 |
Cmip |
c-Maf inducing protein |
24077 |
0.22 |
chr2_121138091_121138271 | 3.57 |
Lcmt2 |
leucine carboxyl methyltransferase 2 |
2197 |
0.15 |
chr8_108101452_108101603 | 3.57 |
Zfhx3 |
zinc finger homeobox 3 |
106968 |
0.07 |
chr8_84131316_84131478 | 3.57 |
Podnl1 |
podocan-like 1 |
3579 |
0.09 |
chr5_117275916_117276216 | 3.56 |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
11459 |
0.11 |
chr11_31747063_31747263 | 3.55 |
Gm38061 |
predicted gene, 38061 |
48515 |
0.13 |
chr2_144073598_144073761 | 3.55 |
Banf2os |
barrier to autointegration factor 2, opposite strand |
4873 |
0.2 |
chr10_84577349_84577529 | 3.55 |
Tcp11l2 |
t-complex 11 (mouse) like 2 |
542 |
0.69 |
chr2_48442189_48442365 | 3.54 |
Gm13481 |
predicted gene 13481 |
14968 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 16.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
3.3 | 13.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
3.1 | 9.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.6 | 10.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.3 | 11.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.3 | 11.3 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.1 | 8.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.0 | 13.8 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.9 | 5.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.8 | 5.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.7 | 5.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.7 | 5.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.7 | 6.6 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.6 | 4.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.6 | 6.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.6 | 3.1 | GO:0070384 | Harderian gland development(GO:0070384) |
1.6 | 4.7 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
1.5 | 4.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.5 | 6.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.5 | 1.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.5 | 3.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.5 | 4.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.5 | 1.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.4 | 7.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.4 | 4.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.4 | 8.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.4 | 7.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.4 | 6.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.4 | 2.7 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.4 | 4.1 | GO:0097503 | sialylation(GO:0097503) |
1.3 | 4.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.3 | 1.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.3 | 2.7 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 8.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.3 | 2.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.3 | 3.9 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.3 | 6.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.3 | 3.9 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.3 | 5.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.3 | 6.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.2 | 3.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.2 | 3.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.2 | 3.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.2 | 3.7 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.2 | 3.7 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.2 | 3.7 | GO:0003166 | bundle of His development(GO:0003166) |
1.2 | 3.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.2 | 3.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.2 | 3.5 | GO:0030242 | pexophagy(GO:0030242) |
1.2 | 1.2 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
1.1 | 2.3 | GO:0051182 | coenzyme transport(GO:0051182) |
1.1 | 3.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 3.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.1 | 7.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.1 | 3.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 4.4 | GO:0019695 | choline metabolic process(GO:0019695) |
1.1 | 3.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 4.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.1 | 8.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.1 | 3.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.1 | 3.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.1 | 2.1 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.0 | 4.1 | GO:0009750 | response to fructose(GO:0009750) |
1.0 | 3.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.0 | 12.3 | GO:0051601 | exocyst localization(GO:0051601) |
1.0 | 2.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.0 | 3.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.0 | 4.0 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.0 | 5.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.0 | 2.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 2.9 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
1.0 | 1.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.0 | 1.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
1.0 | 3.8 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.0 | 3.8 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.9 | 2.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 3.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.9 | 0.9 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.9 | 1.9 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.9 | 2.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 3.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 2.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 1.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.9 | 2.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.9 | 3.7 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.9 | 1.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.9 | 3.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.9 | 2.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 3.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 3.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.9 | 3.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 2.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.9 | 6.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.9 | 0.9 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.9 | 9.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.9 | 1.8 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.9 | 3.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 1.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.9 | 1.7 | GO:0045472 | response to ether(GO:0045472) |
0.9 | 6.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.9 | 3.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 4.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.8 | 1.7 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.8 | 4.2 | GO:0014028 | notochord formation(GO:0014028) |
0.8 | 16.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 2.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.8 | 1.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.8 | 2.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.8 | 2.5 | GO:0040031 | snRNA modification(GO:0040031) |
0.8 | 0.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.8 | 3.3 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.8 | 4.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.8 | 0.8 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.8 | 2.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 4.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.8 | 0.8 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.8 | 0.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.8 | 0.8 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.8 | 2.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.8 | 8.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 0.8 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.8 | 2.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 4.8 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.8 | 2.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.8 | 4.8 | GO:0051775 | response to redox state(GO:0051775) |
0.8 | 8.7 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.8 | 2.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.8 | 3.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.8 | 3.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.8 | 1.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 2.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.8 | 1.6 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.8 | 2.3 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 2.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 2.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.8 | 1.5 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.8 | 4.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 2.3 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.8 | 2.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 6.9 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 4.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.8 | 2.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.8 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 1.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 4.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.8 | 4.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 6.8 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.8 | 5.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.7 | 0.7 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.7 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 1.5 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 2.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 3.7 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.7 | 2.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 0.7 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 0.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.7 | 1.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 2.2 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.7 | 8.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.7 | 1.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.7 | 0.7 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.7 | 2.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 4.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 0.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.7 | 2.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.9 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 4.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.7 | 2.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 0.7 | GO:0051794 | regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.7 | 1.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.7 | 5.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 2.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 6.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.7 | 4.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.7 | 1.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 2.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.7 | 3.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.7 | 2.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.7 | 0.7 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 2.8 | GO:0046909 | intermembrane transport(GO:0046909) |
0.7 | 2.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 2.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 0.7 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.7 | 2.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 1.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.7 | 3.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.7 | 2.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 2.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.7 | 2.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.7 | 2.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.7 | 2.7 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.7 | 0.7 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 2.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 2.6 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 2.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.6 | 3.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 2.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.6 | 2.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.6 | 1.3 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.6 | 1.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.6 | 1.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.6 | 2.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.6 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 1.3 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.6 | 1.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.6 | 1.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 2.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 0.6 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 7.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.6 | 4.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 3.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.6 | 6.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 4.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.6 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 1.8 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.6 | 1.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 1.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.6 | 1.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 1.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 0.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.6 | 1.8 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.6 | 1.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 3.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 1.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.6 | 2.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 1.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 2.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 2.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 1.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.6 | 1.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.6 | 0.6 | GO:0001660 | fever generation(GO:0001660) |
0.6 | 7.0 | GO:0046697 | decidualization(GO:0046697) |
0.6 | 2.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 1.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 3.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 2.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 2.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 1.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 1.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.6 | 1.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 1.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.6 | 1.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.6 | 1.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 1.7 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.6 | 0.6 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.6 | 4.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 1.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 6.7 | GO:0051181 | cofactor transport(GO:0051181) |
0.6 | 1.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.6 | 1.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 2.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.6 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 1.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.5 | 1.1 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.5 | 0.5 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.5 | 3.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 4.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.5 | 3.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.5 | 3.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.5 | 1.1 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 1.6 | GO:0015744 | succinate transport(GO:0015744) |
0.5 | 1.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.5 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 4.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.1 | GO:0003072 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.5 | 1.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.5 | 2.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 2.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 2.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 2.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 4.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 0.5 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.5 | 2.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 1.6 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.5 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
0.5 | 1.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 2.6 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.5 | 1.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 1.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.5 | 10.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 2.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 1.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 1.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.5 | 2.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 3.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.5 | 4.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.5 | 1.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.5 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 5.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 1.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.5 | 3.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.5 | 4.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 7.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 1.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.5 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 5.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 1.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 1.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 2.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.5 | 3.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 1.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 3.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 3.9 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.5 | 1.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 3.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 3.4 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.5 | 2.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 1.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.5 | 2.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.5 | 3.4 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 2.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.5 | 1.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 6.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.5 | 3.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 2.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 1.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.5 | 2.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 1.9 | GO:0003097 | renal water transport(GO:0003097) |
0.5 | 0.9 | GO:0042640 | anagen(GO:0042640) |
0.5 | 1.9 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.5 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.5 | 3.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 1.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 0.9 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.5 | 4.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 0.5 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.5 | 1.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.5 | 0.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 1.8 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.5 | 1.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 1.8 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.5 | 2.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.5 | 1.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 0.5 | GO:0060379 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) cardiac muscle cell myoblast differentiation(GO:0060379) |
0.5 | 1.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 0.5 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.5 | 1.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 2.3 | GO:0060433 | bronchus development(GO:0060433) |
0.5 | 2.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 0.9 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.5 | 1.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.5 | 2.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 3.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 3.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 1.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 1.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 3.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 1.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 3.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.4 | 0.9 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.4 | 3.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 0.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.4 | 2.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 0.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 8.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.4 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 1.3 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 0.9 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 1.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.4 | 1.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 1.3 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 3.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 1.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 0.4 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.4 | 1.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 2.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.4 | 1.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 1.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 2.1 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.4 | 0.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.4 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.4 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 0.4 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 0.8 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 1.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 0.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 1.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.4 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 2.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.4 | 1.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 3.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 1.2 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.4 | 5.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.4 | 1.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 0.4 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.4 | 2.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 0.4 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.4 | 1.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 1.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 1.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 3.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 4.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.4 | 2.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.4 | 1.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 7.4 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 1.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 2.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.4 | 1.5 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.4 | 2.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.1 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 1.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 1.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 2.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 0.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.4 | 0.4 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.4 | 3.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 0.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 4.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
0.4 | 1.5 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.4 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 3.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 0.4 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.4 | 2.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 1.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.4 | 0.7 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 1.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.4 | 2.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 3.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 2.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 0.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.4 | 0.4 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.4 | 0.4 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.4 | 1.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 1.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.4 | 1.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.4 | 0.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.4 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.4 | 3.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 2.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.4 | 1.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.7 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 0.4 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.4 | 1.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 2.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 1.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.4 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 4.3 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.4 | 1.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 1.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.4 | 0.4 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.4 | 1.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 3.6 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 0.7 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 0.7 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.4 | 0.4 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.4 | 1.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 2.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 6.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.4 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 2.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 3.6 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.4 | 1.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.4 | 2.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.4 | 1.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 3.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 0.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.4 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 6.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 1.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 3.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 1.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 3.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 1.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 0.3 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.3 | 0.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 1.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.3 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 0.3 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 1.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 3.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 1.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.3 | GO:0061643 | chemoattraction of axon(GO:0061642) chemorepulsion of axon(GO:0061643) |
0.3 | 0.7 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 0.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 3.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 1.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 2.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 1.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 1.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 4.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 0.7 | GO:0021756 | striatum development(GO:0021756) |
0.3 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 1.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 1.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 1.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 1.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 4.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 7.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 3.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.3 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 2.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 2.6 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 1.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 1.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 1.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.3 | 1.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 5.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 1.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 3.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 0.6 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.3 | 0.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 2.6 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 0.6 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 0.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.9 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.3 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 0.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 2.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 0.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 1.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 2.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.6 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.3 | 1.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.3 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.3 | 0.9 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.6 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.6 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 0.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 2.4 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.3 | 0.9 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 0.6 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.3 | 1.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 2.4 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 1.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 1.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 2.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.6 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.3 | 0.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 5.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.9 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 1.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 1.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 1.2 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.3 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 1.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 3.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.3 | 0.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 2.6 | GO:0071674 | mononuclear cell migration(GO:0071674) |
0.3 | 0.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 1.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.3 | 0.9 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 1.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
0.3 | 1.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 2.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of hair follicle maturation(GO:0048818) |
0.3 | 0.6 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.3 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 0.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 0.6 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 0.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 1.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 2.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 1.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 2.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 2.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 3.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 0.5 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 1.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 4.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 1.9 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 2.1 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.3 | 0.3 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.3 | 1.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 1.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.5 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.3 | 0.3 | GO:0098930 | axonal transport(GO:0098930) |
0.3 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 2.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.3 | GO:1901563 | response to camptothecin(GO:1901563) |
0.3 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.3 | 2.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 0.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 1.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 1.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 1.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 0.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 4.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 2.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 4.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.3 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 3.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 0.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 4.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.3 | 0.3 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 3.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.7 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.2 | 0.2 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 2.0 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 1.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 1.0 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 1.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.5 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 3.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 5.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 1.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 6.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 3.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.9 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.2 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 1.2 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.2 | 1.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 1.6 | GO:0051292 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.2 | 1.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.7 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 4.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 2.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 1.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.5 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 1.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 2.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.9 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 2.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 1.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 1.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.2 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.2 | 4.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 3.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 0.9 | GO:0034982 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.2 | 1.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 1.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.4 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.2 | 1.7 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 7.9 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.2 | 1.7 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.6 | GO:0043383 | negative T cell selection(GO:0043383) |
0.2 | 2.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 0.6 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 1.1 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 1.1 | GO:0051231 | spindle elongation(GO:0051231) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 1.3 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.2 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.4 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 0.2 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.4 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 1.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 2.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.4 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 1.3 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.2 | 2.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 1.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 2.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 2.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 2.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 2.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 1.8 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 2.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 3.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 2.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 2.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 1.5 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.2 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.4 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.2 | 0.2 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 1.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 1.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 2.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 2.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.4 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.2 | 1.5 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 0.2 | GO:2000341 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.2 | 2.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.2 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 1.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.2 | 3.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 2.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.4 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 0.2 | GO:0070100 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.2 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 2.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.5 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 3.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 1.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 0.9 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.2 | 1.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 1.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 1.7 | GO:0001947 | heart looping(GO:0001947) |
0.2 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 2.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 1.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 3.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.0 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.2 | 0.3 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.2 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.3 | GO:0048678 | response to axon injury(GO:0048678) |
0.2 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.2 | GO:0072044 | collecting duct development(GO:0072044) |
0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 1.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 1.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 1.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 1.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 2.0 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.2 | 0.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 0.3 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.2 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 1.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.2 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.2 | 2.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.2 | GO:0048308 | organelle inheritance(GO:0048308) |
0.2 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.2 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 4.5 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.1 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 2.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 1.3 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 2.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 1.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 1.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.5 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 1.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.4 | GO:0002448 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.1 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 1.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 1.6 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.4 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 1.9 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.9 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 1.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 1.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 1.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 1.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 1.6 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.7 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.8 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.1 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 2.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 1.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.4 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 0.5 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.5 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.9 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 2.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 1.0 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.6 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.7 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 0.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 1.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 1.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 6.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 1.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 1.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 1.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 2.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.6 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.2 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.6 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 2.0 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.4 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 1.3 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.6 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 1.0 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.1 | 0.3 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 0.2 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 2.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.4 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.9 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.1 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.3 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 3.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.1 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.2 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.1 | 0.2 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 0.2 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.1 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.5 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.7 | GO:0051297 | microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
0.1 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 1.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 1.4 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.5 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.2 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 1.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.7 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.1 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.1 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.1 | GO:0072683 | T cell extravasation(GO:0072683) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.1 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 2.8 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0045058 | T cell selection(GO:0045058) |
0.1 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.6 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.1 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.1 | 0.2 | GO:0055083 | monovalent inorganic anion homeostasis(GO:0055083) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.2 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.0 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 3.0 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.0 | 0.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.0 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.1 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.7 | GO:2000181 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 1.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.2 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 2.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 1.2 | GO:0043038 | amino acid activation(GO:0043038) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.0 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.5 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.1 | GO:0060343 | trabecula formation(GO:0060343) bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.4 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.0 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 1.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.4 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.2 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:1903010 | regulation of bone development(GO:1903010) |
0.0 | 0.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.0 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.0 | 0.0 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 17.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 5.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.7 | 5.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.5 | 7.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.5 | 4.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 8.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.3 | 4.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.2 | 2.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.2 | 4.8 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 1.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.2 | 4.6 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 5.4 | GO:0005767 | secondary lysosome(GO:0005767) |
1.1 | 1.1 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 1.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.9 | 4.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 2.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 6.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.9 | 3.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 4.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.8 | 2.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.8 | 4.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.8 | 3.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.8 | 4.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 4.6 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 3.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 5.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 2.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 11.3 | GO:0000145 | exocyst(GO:0000145) |
0.7 | 2.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 2.8 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 0.7 | GO:0071010 | prespliceosome(GO:0071010) |
0.7 | 1.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 5.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 5.4 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 3.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.9 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 10.8 | GO:0001741 | XY body(GO:0001741) |
0.6 | 1.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.6 | 3.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 3.6 | GO:1990462 | omegasome(GO:1990462) |
0.6 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 1.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 1.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 1.7 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 2.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 1.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 2.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.6 | 3.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.6 | 0.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.5 | 6.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 2.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 2.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 4.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 1.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 11.0 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 2.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 5.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 4.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 3.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 2.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 1.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 1.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 1.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 1.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 1.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.5 | 1.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 5.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 11.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 4.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 4.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 1.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 1.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 4.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 4.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 1.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 2.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 2.1 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 5.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 0.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 1.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 2.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 1.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 0.8 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 2.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 5.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 0.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 1.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 3.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 4.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 2.6 | GO:0000801 | central element(GO:0000801) |
0.4 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 1.8 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 0.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 1.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 5.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 0.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 5.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 2.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 5.5 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.0 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 3.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 0.7 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.3 | 1.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 2.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 3.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 5.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 16.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 8.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 2.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 0.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 5.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 3.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 6.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 5.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 5.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 1.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 3.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 6.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 3.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 2.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 4.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 7.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 4.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 6.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.9 | GO:0012506 | vesicle membrane(GO:0012506) |
0.2 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 2.9 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 13.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 8.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 12.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 4.3 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 7.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 2.3 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.1 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 2.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 1.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 3.6 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.8 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 1.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 2.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 1.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 3.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 3.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 12.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 6.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 3.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 0.5 | GO:0000803 | sex chromosome(GO:0000803) |
0.2 | 12.5 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 2.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 7.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.8 | GO:0036452 | ESCRT complex(GO:0036452) |
0.2 | 1.8 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 1.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 2.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 4.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 13.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 10.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 3.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 5.8 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 1.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 4.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 4.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 2.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 3.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 3.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 16.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 3.2 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 9.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.8 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 5.8 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 1.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 10.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.5 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.3 | GO:0031674 | I band(GO:0031674) |
0.1 | 10.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 3.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 1.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 28.0 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 6.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 4.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 54.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 6.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 12.6 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 2.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 16.8 | GO:0097708 | intracellular vesicle(GO:0097708) |
0.1 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.6 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 5.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 3.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.4 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 2.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 138.7 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 23.4 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 2.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
4.1 | 12.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
3.7 | 29.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.6 | 7.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.8 | 12.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.7 | 5.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.7 | 6.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.6 | 8.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
1.5 | 4.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.5 | 4.5 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.4 | 5.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.4 | 5.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.4 | 7.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.4 | 4.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.3 | 6.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.3 | 15.7 | GO:0017166 | vinculin binding(GO:0017166) |
1.3 | 3.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.3 | 3.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.3 | 6.3 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.2 | 3.7 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.2 | 1.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.2 | 3.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.2 | 8.3 | GO:0018660 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.2 | 7.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.2 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
1.2 | 4.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.1 | 3.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.1 | 6.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.1 | 3.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.1 | 3.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.1 | 4.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.0 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 9.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 2.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.0 | 2.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 3.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 4.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.9 | 2.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.9 | 4.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.9 | 2.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 0.9 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.9 | 1.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.9 | 3.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 0.9 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.9 | 2.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 1.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.8 | 1.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.8 | 5.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.8 | 5.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 1.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.8 | 4.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 0.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.8 | 3.9 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 0.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.8 | 2.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 2.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 2.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.8 | 2.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.8 | 2.3 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 1.5 | GO:0019841 | retinol binding(GO:0019841) |
0.7 | 2.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 2.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 2.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.7 | 3.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 3.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.7 | 2.8 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 0.7 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.7 | 8.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.7 | 4.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.7 | 4.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.7 | 5.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.7 | 2.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.7 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.7 | 2.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 2.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 3.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 7.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 4.0 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.7 | 4.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 3.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.7 | 9.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.7 | 3.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 6.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 2.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 1.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 2.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 6.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.6 | 1.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 2.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 2.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 3.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 1.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 1.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.6 | 1.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 2.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 2.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 3.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.6 | 7.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 2.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.6 | 2.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.6 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 2.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 2.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.6 | 5.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 3.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 12.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 0.5 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.5 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 1.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.5 | 2.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 4.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.5 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 2.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 6.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 2.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 3.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 1.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 1.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 2.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 8.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 2.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.5 | 8.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 5.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 3.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 9.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 2.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 2.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 7.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 1.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 2.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 4.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 9.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 1.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 2.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 4.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 1.5 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 2.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 4.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 3.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 9.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 3.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.5 | 5.2 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 2.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 0.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 4.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 0.5 | GO:0032142 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.5 | 7.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 1.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 2.7 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 1.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 6.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 0.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 1.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 6.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 1.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 2.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 2.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 3.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 1.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 6.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 3.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 5.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 3.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 1.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 6.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.4 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 1.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 2.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 3.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 2.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 2.0 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 1.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 0.4 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.4 | 6.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 9.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 7.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.4 | 4.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 5.6 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 5.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 1.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 8.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 4.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 4.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 1.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 3.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 2.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 0.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 1.5 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 2.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 1.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 1.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 3.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 1.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 2.2 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 2.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 3.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.4 | 2.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 6.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 1.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 6.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 11.4 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.4 | 1.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 2.4 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.3 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 3.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 4.4 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 0.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 3.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 2.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 4.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 3.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 18.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 9.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 2.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 2.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 4.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.3 | 2.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 1.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.9 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 6.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 2.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 0.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 5.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 0.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.3 | 2.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.3 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 8.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 1.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 2.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 3.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 6.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 2.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 0.6 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 7.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 6.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 3.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 3.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.3 | 1.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 3.3 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 2.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 6.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 0.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.3 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 3.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 2.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 0.8 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 3.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 5.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.3 | 2.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.3 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 7.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 2.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 4.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 3.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 2.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 10.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 2.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 2.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 2.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 5.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 4.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 1.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 2.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 7.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 6.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 12.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.7 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 8.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 4.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 3.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 21.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 3.3 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 3.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 4.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 1.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.6 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 0.8 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 1.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 5.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 4.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 2.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 3.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 3.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 2.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 29.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 2.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 7.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 8.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 1.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 1.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 3.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 1.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 1.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 2.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 2.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 3.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 4.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 1.5 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 2.8 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 3.5 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 24.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 2.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 2.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 2.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 37.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 7.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 6.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 5.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.6 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 0.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 2.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 2.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 2.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 3.7 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 2.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 5.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.7 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 4.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 7.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 1.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 1.3 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 2.4 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 2.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 4.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 2.2 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.6 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 2.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 2.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 2.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 1.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 2.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 4.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 5.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 3.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 1.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 1.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 1.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 1.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 2.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 2.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 2.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 4.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.5 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.1 | 2.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.0 | 25.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 1.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 11.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 9.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 3.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 9.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 8.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 13.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 2.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 30.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 7.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 22.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 13.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 4.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 16.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 11.9 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 11.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 3.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 23.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 8.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 2.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 3.0 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 1.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 3.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 4.7 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 2.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 7.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 6.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 8.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 7.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 1.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 2.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 1.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 6.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 1.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 3.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 5.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 3.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 3.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 1.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 7.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 3.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 48.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 31.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 4.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 6.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 3.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 5.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 5.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 2.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 4.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 3.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 3.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 14.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 32.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.5 | 22.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.1 | 1.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
1.0 | 12.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 7.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 2.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.8 | 14.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.8 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.7 | 7.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 8.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 6.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 5.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 10.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 10.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 0.6 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.6 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 4.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 3.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 1.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 1.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 0.5 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.5 | 4.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 4.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 5.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 5.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 7.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 10.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 4.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 3.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 12.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 10.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 2.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 12.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 3.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 3.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 7.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 7.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 4.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 9.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 1.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 0.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.4 | 3.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 7.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 1.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 14.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 6.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 4.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 5.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 5.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 2.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 6.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 9.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 1.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 4.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 1.3 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.3 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 2.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 4.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 1.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.3 | 1.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 5.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 2.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 3.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 2.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 5.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 15.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 1.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 2.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 2.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 2.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 1.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 7.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 3.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 5.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 0.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 3.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 7.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 5.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 4.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 8.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 10.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 7.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 3.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 19.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 4.5 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.2 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 4.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 8.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 3.7 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 0.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 6.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 4.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 2.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.7 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 7.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 11.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.5 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 6.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 8.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.2 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 1.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |